Fingerprint
Dive into the research topics of 'Comparing the effectiveness of afatinib and osimertinib for patients with pd-l1-positive egfr-mutant non-small cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Comparing the effectiveness of afatinib and osimertinib for patients with pd-l1-positive egfr-mutant non-small cell carcinoma
Minehiko Inomata*, Yosuke Kawashima, Ryota Saito, Daisuke Morinaga, Hitomi Nogawa, Masamichi Sato, Yohei Suzuki, Satoru Yanagisawa, Takashi Kikuchi, Daisuke Jingu, Naruo Yoshimura, Toshiyuki Harada, Eisaku Miyauchi
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations